On December 24, 2013, Michael Rogers informed Coronado Biosciences, Inc. that he was resigning as a director of company, effective December 26, 2013, due to too many commitments.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.87 USD | -5.08% |
|
+3.89% | -37.87% |
05-15 | Fortress Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-15 | Earnings Flash (FBIO) FORTRESS BIOTECH Posts Q1 Revenue $13M | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.87% | 37.24M | |
+0.85% | 92.38B | |
-3.03% | 37.9B | |
-10.46% | 33.73B | |
+74.71% | 27.98B | |
-13.39% | 15.86B | |
-1.08% | 13.97B | |
-11.15% | 11.67B | |
+169.04% | 10.17B | |
-50.19% | 10.04B |
- Stock Market
- Equities
- FBIO Stock
- News Fortress Biotech, Inc.
- Coronado Biosciences, Inc. Announces Resignation of Michael Rogers as Director